Autolus Therapeutics

NASDAQ: AUTL · Real-Time Price · USD
1.28
0.06 (4.92%)
At close: May 15, 2025, 3:19 PM

Autolus Therapeutics Revenue

Autolus Therapeutics reported an annual revenue of $10.12M, reflecting a 496% growth. For the quarter ending March 31, 2025, Autolus Therapeutics generated $8.98M in revenue.
Revenue (ttm)
$10.12M
Revenue Growth
496%
Price / Sales Ratio
59.25
Revenue / Employee
$15.64K
Employees
647
Market Cap
341.99M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.